Post by
Yajne on May 04, 2021 11:42pm
Time to accumulate more IMO...
We are currently in a 'lul' waiting for results on those treated in Ph2, and also on a whole slew of those treated since US sites came on board. Great data on Ph2 trial is the first driver for me. Then there is the COVID angle, where we continue to see new 'variants' for which approved vaccines may or may not be effective, the jury is still out. I happen to believe that TLD1433 will ultimately prove to be extremely effective against these and future viruses, so IMO it's just a matter of time until the NML comes to this conclusion, sometime before end of 2021.
I've decided to move out of one or two stocks that I still believe have upside but have flattened or shown little activity recently. IMO, TLT at $0.22 offers a much better risk/reward ratio over the next 12-18 months. JMHO, DYODD.
Comment by
Yajne on May 04, 2021 11:58pm
P.S. IMO the value of results from NML will depend heavily on our current gov't taking action on the results. This is where I have much less confidence. The NML is located just far enough away from Ottawa that it may take MUCH time before our incompetent leadership actually understands the significance of the results and takes action. IMO this is where most of the risk lies!
Comment by
Rumpl3StiltSkin on May 05, 2021 9:33am
Yaj, I think once the results come out from the NML, TLT stock will go up. I expect the results to be solid. This IP will be wanted by some big pharma, or by Li Ka Shing himself. I'm not worried that the Trudies may fumble here. Covid 19 is a global issue, someone will buy TLT just to get this once it is proven. Oh, and as a bonus a cure for cancer....